Aquestive Therapeutics (AQST) announced the promotion of Sherry Korczynski, from Senior Vice President of Sales and Marketing, to Chief Commercial Officer effective July 22, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AQST:
- Aquestive Therapeutics provides international expansion update for Anaphylm
- Aquestive Therapeutics announces two presentations on Anaphylm
- Positive Outlook for Aquestive Therapeutics Amidst FDA Progress and Strategic Preparations for Anaphylm Launch
- Buy Rating for Aquestive Therapeutics Driven by Anaphylm’s FDA Progress and Market Potential
- FDA Accepts Aquestive’s New Drug Application for Anaphylm